• Molecular NameTroleandomycin
  • SynonymOleandocetine; Oleandomycin triacetate; Oleandomycin triacetyl ester; Oleandomycin, triacetate (ester); Triacetyloleandomycin
  • Weight813.979
  • Drugbank_IDDB01361
  • ACS_NON/A
  • Show 3D model
  • LogP (experiment)N/A
  • LogP (predicted, AB/LogP v2.0)4.65
  • pka6.6
  • LogD (pH=7, predicted)4.37
  • Solubility (experiment)Insoluble
  • LogS (predicted, ACD/Labs)(ph=7)-0.46
  • LogSw (predicted, AB/LogsW2.0)0.2
  • Sw (mg/ml) (predicted, ACD/Labs)35.56
  • No.of HBond Donors0
  • No.of HBond Acceptors16
  • No.of Rotatable Bonds12
  • TPSA193.42
  • StatusFDA approved
  • AdministrationN/A
  • PharmacologyA macrolide antibiotic.
  • Absorption_valueN/A
  • Absorption (description)N/A
  • Caco_2N/A
  • BioavailabilityN/A
  • Protein bindingN/A
  • Volume of distribution (VD)N/A
  • Blood/Plasma Partitioning ratio (D_blood)N/A
  • MetabollsmN/A
  • Half lifeN/A
  • ExcretionN/A
  • Urinary ExcretionN/A
  • CleranceN/A
  • ToxicitySymptoms of overdose include diarrhea, nausea, stomach cramps, and vomiting.
  • LD50 (rat)N/A
  • LD50 (mouse)N/A